Autoimmune disease caused by spike protein and potential management approaches

0 Views
Published
Autoimmune disease caused by spike protein and potential management approaches

There is growing evidence that spike protein could result in anti-ACE2 antibodies. This in most cases is a normal (homeostatic) mechanism. However, in some individuals it can last longer and become problematic. Let's review the possible therapies in light of the pathogenesis. Educational material only. Not a medical advice. Please discuss these therapies with your doctor and follow his advice.

Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US


Reference URL list from Tuesday, Dec. 28 2021

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
https://www.drbeen.com/

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker | Signal Transduction and Targeted Therapy
https://www.nature.com/articles/s41392-021-00740-y

Development of ACE2 autoantibodies after SARS-CoV-2 infection - PMC
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8415618/

I-RECOVER Protocol - FLCCC | Front Line COVID-19 Critical Care Alliance
https://covid19criticalcare.com/covid-19-protocols/i-recover-protocol/

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Category
Management
Be the first to comment